ADMA Biologics, Inc. (ADMA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.67 |
| Open | 6.71 |
| Bid | 6.72 x 800 |
| Ask | 6.75 x 800 |
| Day's range | 6.60 - 6.75 |
| 52-week range | 3.06 - 6.76 |
| Volume | |
| Avg. volume | 2,525,216 |
| Market cap | 1.562B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Adma Biologics (ADMA) Rises Higher Than Market: Key Facts
Adma Biologics (ADMA) reachead $6.74 at the closing of the latest trading day, reflecting a +1.05% change compared to its last close.
- Zacks
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
- Zacks
What's in Store for ADMA Biologics (ADMA) in Q1 Earnings?
On ADMA Biologics' (ADMA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its marketed products, Bivigam, Asceniv and Nabi-HB.
© 2024 Yahoo. All rights reserved.